Opus Genetics, a patient-first, clinical-stage gene therapy company developing treatments for inherited retinal diseases, and the Department of Health – Abu Dhabi (DoH), the Emirate's regulator of the healthcare sector, signed a Memorandum of...
Amplitude Vascular Systems (AVS), a medical device company focused on the safe and effective treatment of severely calcified arterial disease, declared that it has received an investigational device exemption (IDE) from the United States Food and...
Orchid Pharma has secured Drugs Controller General of India (DCGI) endorsement for the manufacturing and promoting of its invented New Chemical Entity active pharmaceutical ingredient (API), enmetazobactam.DCGI has conceded consent to produce and...
Annogen, a biotechnology firm declared a research collaboration with Orchard Therapeutics, a worldwide gene therapy treatment pioneer, for the recognizable proof of immune cell-explicit human advertisers for use in specific pre-clinical...
Torrent Pharmaceuticals announced that it has signed a non-exclusive patent licensing arrangement with Takeda to commercialize Vonoprazan in India. Vonoprozan is a new potassium-competitive acid blocker (P-CAB) that treats acid-related illnesses...
UNION Therapeutics A/S (Association), a clinical stage and drug improvement organization focused on immunology, reports effective culmination of the ADESOS stage 2b, randomized, dose finding study assessing orismilast as an oral treatment in 233...
.jpg)
